#EMA

Understanding the Reflection Paper on the Qualification of Non-Mutagenic Impurities: A Regulatory Perspective

by Gabriele Pincitore|12 Maggio 202512 Maggio 2025|Blog, Pharma

Introduction In the complex world of pharmaceutical development, ensuring drug safety and efficacy is paramount....

Better models to shed light on the mutagenicity of N-nitrosamines

by admin|8 Febbraio 20228 Febbraio 2022|Pharma

[vc_acf field_group="1287" field_from_1287="field_5a155fb5628a4"] [vc_acf field_group="1287" show_label="yes" field_from_1287="field_5a1538a612368"][vc_acf field_group="1287" show_label="yes" field_from_1287="field_5a15385612367"][vc_acf field_group="1287" show_label="yes" field_from_1287="field_5a1539cf1236a"] [latest_post type="minimal"...